BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26983714)

  • 1. Bis(maltolato)oxovanadium(IV) (BMOV) Attenuates Apoptosis in High Glucose-Treated Cardiac Cells and Diabetic Rat Hearts by Regulating the Unfolded Protein Responses (UPRs).
    Cong XQ; Piao MH; Li Y; Xie L; Liu Y
    Biol Trace Elem Res; 2016 Oct; 173(2):390-8. PubMed ID: 26983714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
    Dabroś W; Dziga D; Kordowiak AM
    Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV).
    Yuen VG; Orvig C; Thompson KH; McNeill JH
    Can J Physiol Pharmacol; 1993; 71(3-4):270-6. PubMed ID: 8402391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hyperglycemia stimulated myocardial endoplasmic reticulum (ER) stress contributes to diabetic cardiomyopathy in the transgenic non-obese type 2 diabetic rats: a differential role of unfolded protein response (UPR) signaling proteins.
    Lakshmanan AP; Harima M; Suzuki K; Soetikno V; Nagata M; Nakamura T; Takahashi T; Sone H; Kawachi H; Watanabe K
    Int J Biochem Cell Biol; 2013 Feb; 45(2):438-47. PubMed ID: 23032698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo.
    Marzban L; Rahimian R; Brownsey RW; McNeill JH
    Endocrinology; 2002 Dec; 143(12):4636-45. PubMed ID: 12446591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV).
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1993; 71(3-4):263-9. PubMed ID: 8402390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats.
    Yuen VG; Orvig C; McNeill JH
    Am J Physiol; 1997 Jan; 272(1 Pt 1):E30-5. PubMed ID: 9038848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bis(maltolato) oxovanadium (IV) on protein serine kinases in skeletal muscle of streptozotocin-diabetic rats.
    Bhanot S; Girn J; Poucheret P; McNeill JH
    Mol Cell Biochem; 1999 Dec; 202(1-2):131-40. PubMed ID: 10706003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes.
    Shinde UA; Mehta AA; Goyal RK
    Indian J Exp Biol; 2001 Sep; 39(9):864-70. PubMed ID: 11831366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.
    Zhang SQ; Zhong XY; Chen GH; Lu WL; Zhang Q
    J Pharm Pharmacol; 2008 Jan; 60(1):99-105. PubMed ID: 18088510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of insulin and bis(maltolato)oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats.
    Marzban L; Bhanot S; McNeill JH
    Mol Cell Biochem; 2001 Jul; 223(1-2):147-57. PubMed ID: 11681716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragalus polysaccharides inhibits cardiomyocyte apoptosis during diabetic cardiomyopathy via the endoplasmic reticulum stress pathway.
    Sun S; Yang S; An N; Wang G; Xu Q; Liu J; Mao Y
    J Ethnopharmacol; 2019 Jun; 238():111857. PubMed ID: 30959142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptozotocin-induced alterations in rat liver Golgi complexes are ameliorated by BMOV [Bis(maltolato)oxovanadium(IV)] activity.
    Kordowiak AM; Dziga D; Dabroś W
    Horm Metab Res; 2004 Mar; 36(3):148-54. PubMed ID: 15057667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic oral administration of bis(maltolato)oxovanadium(IV) in Zucker diabetic fatty (ZDF) rats.
    Yuen VG; Vera E; Battell ML; Li WM; McNeill JH
    Diabetes Res Clin Pract; 1999 Jan; 43(1):9-19. PubMed ID: 10199584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: An insight into endoplasmic reticulum stress response mechanism.
    Guo R; Liu W; Liu B; Zhang B; Li W; Xu Y
    Int J Cardiol; 2015 Jul; 191():36-45. PubMed ID: 25965594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of vanadium on GLUT4 translocation in cardiac tissue of STZ-diabetic rats.
    Li SH; McNeill JH
    Mol Cell Biochem; 2001 Jan; 217(1-2):121-9. PubMed ID: 11269655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.
    Winter CL; Lange JS; Davis MG; Gerwe GS; Downs TR; Peters KG; Kasibhatla B
    Exp Biol Med (Maywood); 2005 Mar; 230(3):207-16. PubMed ID: 15734724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-diabetic bis(maltolato)oxovanadium(IV) decreases lipid order while increasing insulin receptor localization in membrane microdomains.
    Winter PW; Al-Qatati A; Wolf-Ringwall AL; Schoeberl S; Chatterjee PB; Barisas BG; Roess DA; Crans DC
    Dalton Trans; 2012 Jun; 41(21):6419-30. PubMed ID: 22569684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in iron metabolism and oxidative status in STZ-induced diabetic rats treated with bis(maltolato) oxovanadium (IV) as an antidiabetic agent.
    Sánchez-González C; López-Chaves C; Trenzado CE; Aranda P; López-Jurado M; Gómez-Aracena J; Montes-Bayón M; Sanz-Medel A; Llopis J
    ScientificWorldJournal; 2014; 2014():706074. PubMed ID: 24511298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.